RxSight, Inc. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2025-04-21: Measure Revenue.
- 2025-04-21: Measure LAL/LAL+ Revenue.
- 2025-04-21: Measure Gross Margin.
- 2025-04-21: Measure Cash.
| Proxy filed | Measure |
|---|---|
| 2025-04-21 | Revenue |
| 2025-04-21 | LAL/LAL+ Revenue |
| 2025-04-21 | Gross Margin |
| 2025-04-21 | Cash |
| 2026-04-28 | Revenue |
| 2026-04-28 | LAL/LAL+ Revenue |
| 2026-04-28 | Gross Margin |
| 2026-04-28 | Cash |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |